Skip to main content
Clinical Trials/NCT00669682
NCT00669682
Completed
Not Applicable

T-wave Alternans and Intrathoracic Impedance Measurements

Columbia University1 site in 1 country9 target enrollmentAugust 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congestive Heart Failure
Sponsor
Columbia University
Enrollment
9
Locations
1
Primary Endpoint
Number of Positive Twave Studies and Concurrent Positive Optivol Measurement
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

T-wave alternans is a test that is currently being used to risk stratify patients with structural heart disease for sudden cardiac death. The mechanism of T-wave alternans is unclear, but may share a common abnormality with conditions of cardiac fluid overload such as heart failure, which is altered intracellular calcium handling. Current Medtronic implantable defibrillators have the capability of monitoring cardiac fluid status via transthoracic impedance measurements.

The purpose of this study is to determine if a correlation exists between T-wave alternans status and cardiac volume status, as determined by transthoracic impedance measurements. Secondarily, the study seeks to examine the relationship between arrhythmia frequency and T-wave alternans or cardiac volume status.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
April 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jose M. Dizon

Assoc Professor of Clinical, Department of Cardiology

Columbia University

Eligibility Criteria

Inclusion Criteria

  • Class III or IV heart failure patients with a chronically implanted Medtronic biventricular defibrillator system capable of monitoring intrathoracic fluid volume.

Exclusion Criteria

  • no active ischemia or pulmonary edema, atrial fibrillation, complete heart block

Outcomes

Primary Outcomes

Number of Positive Twave Studies and Concurrent Positive Optivol Measurement

Time Frame: upto 3 years

We wanted to examine whether positive Optivol status corresponded to a higher likelihood of a positive T wave study. The T wave alternans result is determined by a proprietary device that measures T wave and reports the result as negative, positive, or indeterminate. The Optivol measurement is obtained through transthoracic impedance values in the implanted device. We investigated the correlation between Optivol status and T wave alternans status.

Study Sites (1)

Loading locations...

Similar Trials